Industry Alliance for Microphysiological Systems

{
  "notary": {
    "name": "Berna Akdeniz",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-03-18",
    "filing_date": "2026-03-11",
    "act_kind_objet": "Objet de l\u0027acte:",
    "is_private_deed": false
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2026-01-07",
    "unanimous": true
  },
  "founders": [
    {
      "org": {
        "kbo": "0840.248.744",
        "name": "NETRI",
        "address": "76 Rue Georges Gouy, 69007 Lyon, France",
        "country": "FR",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": "R.C.S. Lyon",
        "foreign_register_number": "840248744"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "Mimetas",
        "address": "De Limes 7, 2342 Oegstgeest, Pays-Bas",
        "country": "NL",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": null,
        "foreign_register_number": "53898737"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "InSphero",
        "address": "Wagistrasse 27A, 8952 Schlieren, Suisse",
        "country": "CH",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": null,
        "foreign_register_number": "CH-020.3.033.659-7"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "TissUse GmbH",
        "address": "Oudenarder Str. 16, 13347 Berlin, Allemagne",
        "country": "DE",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": "HRB 173785 B",
        "foreign_register_number": "HRB 173785 B"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "chrn on-chip biotechnologies B.V. (chiron)",
        "address": "Gaetano Martinolaan 63A, 63 - 65, 6229 GS Maastricht, Pays-Bas",
        "country": "NL",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": null,
        "foreign_register_number": "87226162"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "Biomimx Srl",
        "address": "Viale Decumano 41, 20157 Milano, Italie",
        "country": "IT",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": null,
        "foreign_register_number": "09910070961"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "React4Life",
        "address": "via D. Fiasella 1/11, 16124 Genova, Italie",
        "country": "IT",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": "VAT",
        "foreign_register_number": "02436280990"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0475.985.759",
        "name": "Alveolix",
        "address": "Freiburgstrasse 3, 3010 Beme, Suisse",
        "country": "CH",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": null,
        "foreign_register_number": "CHE-475.985.759"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "Dynamic42 GmbH",
        "address": "Winzerlaer Str. 2, 07745 Jena, Allemagne",
        "country": "DE",
        "legal_form": "Soci\u00E9t\u00E9",
        "foreign_register_name": "HRB 514422",
        "foreign_register_number": "HRB514422"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": null,
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 0,
      "amount_subscribed_eur": 0.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "voorwerp": {
    "full_text": "Constitution de l\u0027association, statuts et nomination administrateurs\n\nL\u0027Association est d\u00E9nomm\u00E9e Industry Alliance for Microphysiological Systems, ou dans sa forme abr\u00E9g\u00E9e \u0022IAMPS\u0022 (ci-apr\u00E8s \u003C l\u0027Association \u00BB). Cette d\u00E9nomination doit figurer dans tous les actes, factures, annonces, publications, lettres, bons de commande et autres documents \u00E9mis par L\u0027Association, et doit \u00EAtre imm\u00E9diatement pr\u00E9c\u00E9d\u00E9e ou suivie des mots \u003C association sans but lucratif \u003E ou de l\u0027abr\u00E9viation \u003C ASBL \u00BB, avec l\u0027indication pr\u00E9cise de l\u0027adresse du si\u00E8ge de l\u0027Association.\n\nL\u0027Association est constitu\u00E9e en tant qu\u0027association sans but lucratif de droit belge.\n\nLe si\u00E8ge de l\u0027Association est \u00E9tabli en R\u00E9gion de Bruxelles-Capitale. Le si\u00E8ge peut \u00EAtre transf\u00E9r\u00E9 vers tout autre lieu en Belgique par d\u00E9cision du Conseil d\u0027Administration, pour autant que ce transfert n\u0027implique pas de modification de la langue des pr\u00E9sents statuts conform\u00E9ment aux dispositions l\u00E9gales r\u00E9gissant l\u0027emploi des langues officielles en Belgique.\n\nSi le transfert du si\u00E8ge de l\u0027Association implique un changement de la langue des pr\u00E9sents statuts conform\u00E9ment aux dispositions l\u00E9gales r\u00E9gissant l\u0027emploi des langues officielles en Belgique, seule l\u0027Assembl\u00E9e G\u00E9n\u00E9rale sera comp\u00E9tente pour d\u00E9cider du transfert du siege de l\u0027Association, conform\u00E9ment au quorum de pr\u00E9sence et \u00E0 la majorit\u00E9 de vote requis pour la modification des statuts.\n\nL\u0027Association est constitu\u00E9e pour une dur\u00E9e illimit\u00E9e.\n\nLes objectifs de l\u0027Association sont :\n\ni. d\u0027unir, repr\u00E9senter et renforcer les entreprises \u00E9tablies \u00E0 travers l\u0027Europe qui d\u00E9veloppent des syst\u00E8mes microphysiologiques, y compris mais sans limitation les organes-sur-puce, les organo\u00EFdes et autres mod\u00E8les biologiques avanc\u00E9s transposable \u00E0 humain; ces technologies ont pour finalit\u00E9 de reproduire la physiologie humaine de mani\u00E8re plus fid\u00E8le que les mod\u00E8les traditionnels, d\u0027acc\u00E9l\u00E9rer le progr\u00E8s scientifique, d\u0027am\u00E9liorer la sant\u00E9 publique et de r\u00E9duire l\u0027utilisation d\u0027animaux dans la recherche;\n\nii. de rassembler les acteurs intervenant dans ce secteur, tels que les startups, les PME, ainsi que tout autre acteur industriel ou public partageant un engagement commun en faveur du d\u00E9veloppement d\u0027une science centr\u00E9e sur l\u0027\u00EAtre humain et du d\u00E9ploiement d\u0027outils innovants au b\u00E9n\u00E9fice des patients, des chercheurs et de la soci\u00E9t\u00E9;\n\niii. de construire un \u00E9cosyst\u00E8me industriel europ\u00E9en connect\u00E9 et influent, capable de peser sur les politiques scientifiques et r\u00E9glementaires de l\u0027Union europ\u00E9enne.\n\nL\u0027Association peut accomplir des actes, prendre des mesures et s\u0027engager dans toutes activit\u00E9s jug\u00E9es appropri\u00E9es ou utiles en vue de la r\u00E9alisation de son objet et de ses objectifs. L\u0027Association peut r\u00E9aliser toutes activit\u00E9s directement ou indirectement li\u00E9es \u00E0 son but ou \u00E0 ses objectifs. Ces activit\u00E9s peuvent inclure, sans toutefois s\u0027y limiter :\n\ni. Strat\u00E9gie politique et d\u00E9veloppement de r\u00E9seau\n\u2022 Collecter, analyser et partager des informations sur les politiques de l\u0027UE et des \u00C9tats membres pertinents pour le secteur des MPS, et d\u00E9velopper une strat\u00E9gie politique d\u0027anticipation pour l\u0027industrie;\n\u2022 Faciliter la communication et la coop\u00E9ration entre les membres par le biais de canaux d\u00E9di\u00E9s, de mises \u00E0 jour r\u00E9guli\u00E8res et de groupes de travail;\n\u2022 Cr\u00E9er un \u00E9cosyst\u00E8me MPS europ\u00E9en coh\u00E9sif gr\u00E2ce \u00E0 un tissage de r\u00E9seau et \u00E0 la coop\u00E9ration entre entreprises.\n\nii. Affaires publiques et repr\u00E9sentation\n\u2022 Formuler des positions politiques unifi\u00E9es et repr\u00E9senter le secteur aupr\u00E8s des institutions europ\u00E9ennes et des autorit\u00E9s nationales par le biais de prises de position, de briefings, d\u0027amendements et de documents d\u0027orientation;\n\u2022 Plaider en faveur de l\u0027int\u00E9gration et de la reconnaissance des technologies MPS dans les cadres r\u00E9glementaires europ\u00E9ens;\n\u2022 Soutenir l\u0027\u00E9laboration et l\u0027harmonisation de crit\u00E8res d\u0027acceptation, de lignes directrices et de normes pour les MPS dans l\u0027ensemble des agences de l\u0027UE, des \u00C9tats membres et des industries cl\u00E9s telles que les produits pharmaceutiques, les produits chimiques, les produits alimentaires et les cosm\u00E9tiques.\n\niii. Collaboration strat\u00E9gique et initiatives au niveau de l\u0027Union Europ\u00E9enne (UE)\n\u2022 \u00C9tablir et coordonner des collaborations au niveau europ\u00E9en impliquant les d\u00E9veloppeurs de MPS, les partenaires de l\u0027industrie pharmaceutique et les institutions de l\u0027UE;\n\u2022 Soutenir la mise en place d\u0027initiatives financ\u00E9es ou cofinanc\u00E9es par l\u0027UE qui acc\u00E9l\u00E8rent l\u0027adoption des technologies MPS.\n\niv. Sensibilisation et communication publique\n\u2022 Am\u00E9liorer, aupr\u00E8s des d\u00E9cideurs politiques de l\u0027UE, la visibilit\u00E9 des MPS en tant que technologies strat\u00E9giques qui peuvent am\u00E9liorer la recherche scientifique, avoir un impact positif sur les patients et r\u00E9duire l\u0027utilisation d\u0027animaux;\n\u2022 Mobiliser les m\u00E9dias et les plateformes num\u00E9riques pour communiquer les progr\u00E8s, l\u0027impact et les r\u00E9ussites de la communaut\u00E9 MPS.\n\nv. Divers\n\u2022 Mener toute autre action jug\u00E9e utile ou appropri\u00E9e pour la poursuite des buts et objectifs de l\u0027Association.\n\nAf",
    "is_lucrative": false,
    "short_summary": "Constitution d\u0027une association sans but lucratif europ\u00E9enne d\u00E9di\u00E9e \u00E0 la promotion et au d\u00E9veloppement des syst\u00E8mes microphysiologiques, notamment les organes-sur-puce, les organo\u00EFdes et mod\u00E8les biologiques avanc\u00E9s, afin d\u0027am\u00E9liorer la recherche scientifique, r\u00E9duire l\u0027utilisation d\u0027animaux et influencer les politiques r\u00E9glementaires de l\u0027UE."
  },
  "governance": {
    "organ_kind": "raad_van_bestuur",
    "n_directors_max": 20,
    "n_directors_min": 3,
    "representation_clause": "twee bestuurders gezamenlijk",
    "co_signature_threshold_eur": null
  },
  "fiscal_year": {
    "end_mm_dd": "12-31",
    "start_mm_dd": "01-01",
    "first_exercise_end_date": "2026-12-31",
    "is_prolonged_first_exercise": false
  },
  "agm_schedule": {
    "time": null,
    "month": 6,
    "rule_text": "premier jeudi de juin"
  },
  "founding_event": {
    "n_shares_total": 0,
    "n_share_classes": 0,
    "bank_attestation": null,
    "amount_paid_in_eur": 0.0,
    "incorporation_date": "2026-01-07",
    "amount_subscribed_eur": 0.0,
    "art_5_8_no_payment_due": true,
    "pre_incorporation_activity_from_date": "2025-10-07"
  },
  "subject_company": {
    "kbo": "1035.385.225",
    "email": null,
    "region": "brussels_hoofdstedelijk_gewest",
    "website": null,
    "name_full": "Industry Alliance for Microphysiological Systems",
    "legal_form": "ASBL",
    "name_abbreviated": "IAMPS",
    "zetel_address_raw": "Rue Belliard 40, 1040 Etterbeek, Belgique",
    "equity_account_type": "unavailable",
    "_kbo_filled_from_list": true
  },
  "initial_directors": [
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": "0840.248.744",
        "name": "NETRI",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Thibault HONEGGER",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "Mimetas",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Jos JOORE",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "InSphero",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Paul Cl\u00E9men\u00E7on",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "TissUse GmbH",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Dr. Reyk HORLAND",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "chrn on-chip biotechnologies B.V. (chiron)",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Dustin DOPSA",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "BiomimX Srl",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Paola OCCHETTA",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "React4Life",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Maurizio AIELLO",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": "0475.985.759",
        "name": "Alveolix",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Nina HOBI",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": null,
        "name": "Dynamic42 GmbH",
        "legal_form": "Soci\u00E9t\u00E9"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "Dr. Martin RAASCH",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": {
        "date": "2026-03-11",
        "numac_or_number": "2522"
      }
    }
  ],
  "co_filed_documents": [
    "expedition",
    "statuten",
    "volmacht",
    "plan financier",
    "bankattest"
  ],
  "post_incorporation_mandates": [
    {
      "kind": "volmacht_publication",
      "holder_org_kbo": null,
      "holder_org_name": "Kadrant",
      "with_substitution": true,
      "holder_person_name": "Giulia Mauri"
    },
    {
      "kind": "volmacht_publication",
      "holder_org_kbo": null,
      "holder_org_name": "Kadrant",
      "with_substitution": true,
      "holder_person_name": "Berna Akdeniz"
    }
  ]
}